Nicholas Conrad Smith
PRESIDENT AND CFO · Alto Neuroscience, Inc.
IndividualSelling only
- 2025
- Oct 5, 2026
- 5
Other insiders active in the same sector
No other insider has filed at Nicholas Conrad Smith's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $83.13M in VOR purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nicholas Conrad Smith?
Nicholas Conrad Smith is a corporate insider, tracked as PRESIDENT AND CFO of Alto Neuroscience, Inc. (ANRO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nicholas Conrad Smith submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Nicholas Conrad Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($3.57M) across all tracked filings.
